Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Κατάταξη σε μετοχές #340
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Τιμή μετοχής
$48.86
Κεφαλαιοποίηση
$72.62B
Αλλαγή (1 ημέρα)
1.69%
Αλλαγή (1 έτος)
-54.20%
Χώρα
US
Εμπόριο Boston Scientific Corporation (BSX)

Κατηγορία

Αριθμός κυκλοφορούντων μετοχών για Boston Scientific Corporation (BSX)
Αριθμός κυκλοφορούντων μετοχών στις June 2026: 1.48B
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Boston Scientific Corporation, ο τρέχων αριθμός κυκλοφορούντων μετοχών είναι 1.48B. Στο τέλος του December 2024, η εταιρεία είχε 1.47B κυκλοφορούντες μετοχές. Ο αριθμός των κυκλοφορούντων μετοχών επηρεάζεται συνήθως από διασπάσεις μετοχών και επαναγορές.
Ιστορικό κυκλοφορούντων μετοχών για Boston Scientific Corporation (BSX) από 2000 έως 2026
Κυκλοφορούντες μετοχές στο τέλος κάθε έτους
Έτος Κυκλοφορούντες μετοχές Αλλαγή
2026 (TTM) 1.48B -0.19%
2025 1.48B 0.60%
2024 1.47B 1.27%
2023 1.45B 1.57%
2022 1.43B 0.58%
2021 1.42B 0.40%
2020 1.42B 1.81%
2019 1.39B 0.76%
2018 1.38B 0.80%
2017 1.37B 0.92%
2016 1.36B 2.25%
2015 1.33B 0.26%
2014 1.32B -1.26%
2013 1.34B -4.66%
2012 1.41B -6.80%
2011 1.51B -0.56%
2010 1.52B 0.66%
2009 1.51B 0.63%
2008 1.50B 0.78%
2007 1.49B 16.74%
2006 1.27B 54.14%
2005 826.32M -1.18%
2004 836.22M 0.98%
2003 828.07M 2.12%
2002 810.87M -2.40%
2001 830.77M 2.45%
2000 810.87M 0.00%
Κυκλοφορούντες μετοχές για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Κυκλοφορούντες μετοχές Διαφορά Χώρα
1.74B 17.96%
US
383.50M -74.05%
US
1.28B -13.23%
IE
576.40M -60.99%
US
- -
DE